Results 221 to 230 of about 326,497 (313)

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

[Propafenone--a promising anti-arrhythmia agent?].

Sbornik vedeckych praci Lekarske fakulty Karlovy univerzity v Hradci Kralove. Supplementum, 1991
Propafenone hydrochloride (Rytmonorm, Prolekofen) belongs to the membranous anti-arrhythmical agents of IC group. Simultaneously, it produces a mild beta blocking effect and blocks slow Calcium channels. The mentioned agent is of current use in treating both the supraventricular and ventricular tachyarrhythmias.
openaire   +1 more source

[Arrhythmogenic effects of anti-arrhythmia agents].

Therapie, 1986
F, Fillette, B, Dupuis, Y, Grosgogeat
openaire   +2 more sources

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

[Pharmacological properties and therapeutic effectiveness of ajmalin--a new anti-arrhythmia agent. (Review of the literature)].

, 1965
Gendenshteĭn Ei, Davidovskiĭ Nm
openalex  

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

[Lidocaine as an anti-arrhythmia agent. The pharmacological, experimental and clinical background for its use].

, 1969
E Flensted-Jensen
openalex  

Recent progress in the treatment of cancer in children

Ca-A Cancer Journal for Clinicians, 2021
Theodore W Laetsch
exaly  

[Current anti-arrhythmia agents--methods of administration].

, 1969
Kazuhisa Hosono, F Takei
openalex  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly